Neogen Corporation

NEOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item May 2024 Feb 2024 Nov 2023 Aug 2023 May 2023 Feb 2023 Nov 2022 Aug 2022
Revenue $236.8M $228.8M $229.6M $229.0M $241.8M $218.3M $230.0M $132.3M
Cost of Revenue $123.3M $111.9M $112.9M $112.2M $118.6M $110.3M $117.5M $70.1M
Gross Profit $113.5M $116.9M $116.8M $116.8M $123.2M $108.0M $112.5M $62.3M
Gross Margin 47.9% 51.1% 50.9% 51.0% 50.9% 49.5% 48.9% 47.0%
Operating Expenses
Research & Development $5.2M $4.9M $5.8M $6.7M $7.1M $7.3M $6.8M $4.9M
SG&A Expense $51.0M $52.1M $51.7M $45.1M $49.8M $46.4M $77.0M $27.9M
Operating Income $13.0M $12.0M $14.5M $19.1M $23.4M $15.7M $-7.7M $6.1M
Operating Margin 5.5% 5.3% 6.3% 8.4% 9.7% 7.2% -3.3% 4.6%
Interest Expense $10.8M $10.5M $10.3M $10.6M $9.1M $8.3M
Pretax Income $-6.4M $-5.8M $-3.7M $1.7M $7.7M $-2.3M $-34.1M $6.7M
Income Tax Expense $-1.0M $-3.8M $-260.0K $160.0K $2.1M $-10.5M $7.8M $1.5M
Net Income $-5.4M $-2.0M $-3.5M $1.5M $5.6M $8.2M $-41.8M $5.2M
Net Margin -2.3% -0.9% -1.5% 0.7% 2.3% 3.8% -18.2% 3.9%
EPS (Basic) $-0.02 $-0.01 $-0.02 $0.01 $-0.02 $0.04 $-0.19 $0.05
EPS (Diluted) $-0.02 $-0.01 $-0.02 $0.01 $-0.02 $0.04 $-0.19 $0.05
Shares Outstanding (Basic) 216.5M 216.6M 216.4M 216.3M 188.9M 216.2M 216.1M 107.8M
Shares Outstanding (Diluted) 216.5M 216.6M 216.4M 216.8M 188.9M 216.4M 216.1M 107.9M
Dividends Per Share
← Newer Page 2 of 8 Older →